Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2011) 25 P149

Diabetes, metabolism and cardiovascular

Improvement of cardiovascular risk factors 12 months after Roux-en-Y surgery

Alison Dawson1, Thozhukat Sathyapalan3, Peter Sedman2, Eric Kilpatrick2 & Stephen Atkin3

1University of Hull, Hull, UK; 2Hull and East Yorkshire NHS Trust, Hull, UK; 3Hull York Medical School, Hull, UK.

Background: Obesity is associated with increased insulin resistance, type 2 diabetes and increased cardiovascular risk leading to atherosclerosis. Bariatric surgery has been shown to improve some of these factors in obese patients with glucose intolerance. A form of bariatric surgery is the Roux-en-Y procedure which can result in greater weight loss and restriction with less malabsorption than other procedures (such as the bilious-pancreatic diversion); but the effect of some metabolic parameters on patients with normal glucose tolerance is not fully known.

Aim: To examine the effect of Roux-en-Y surgery on endothelial function and metabolic parameters in patients without type 2 diabetes.

Method: Ten patients with a body mass index (BMI) >40 kg/m2 were recruited and followed up for 12 months after surgery. Fasting blood samples were taken before surgery and at 3 monthly intervals after surgery. Endothelial function (RH-PAT) was also determined at these time points using peripheral arterial tonometry (endoPAT2000) technique. A 75 g oral glucose tolerance test was performed at the start of the study to exclude diabetes.

Results: BMI reduced from 49.47±7.54 kg/m2 pre surgery to 33.32±5.21 (P≤0.001) 12 months after surgery. Fasting glucose levels reduced from 5.26±0.78 mmol/l to 4.56±0.33 (P=0.02), C-reactive protein (CRP) from 7.22±7.81 mmol/l to 2.41±4.41 (P=0.039). Systolic blood pressure reduced from 129.64±16.18 mmHg to 114.22±10.71 (P=0.05) and diastolic blood pressure reduced from 76.55±14.24 mmHg to 72.56±7.50 (P=0.95). RH-PAT improved from 1.80±0.39 to 2.01±0.54 (P=0.035).

Conclusion: Roux-en-Y surgery in patients with normal glucose tolerance improved cardiovascular risk factors. Thus is shown by a reduction in the inflammatory markers CRP, a reduction in systolic and diastolic blood pressure and also improved endothelial function 12 months after surgery.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts

No recent abstracts.